香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容 而引致之任何損失承擔任何責任。 Da Sen Holdings Group Limited 大 森 控 股 集 團 有 限 公 司 ( 於開曼群島註冊成立的有限公司 ) (股份代號: 1580) 延遲寄發通函 有關涉及根據特別授權發行代價股份 以收購目標公司之主要交易 茲提述大森控股集團有限公司（「本公司」）日期為二零二六年一月十八日內容有關涉及根 據特別授權發行代價股份以收購目標公司之主要交易之公告（「該公告」）。除文義另有所 指外，本公告所用詞彙與該公告所定義者具有相同意義。 誠如該公告所披露，一份載有關於收購、協議及根據特別授權發行代價股份之進一步詳情之 通函（「該通函」）預期將於二零二六年二月十三日或之前寄發予股東。 由於公司需要更多時間來準備和最終確定該通函中包含的某些信息，其中包括但不限於目標 公司的財務信息，目前預期該通函之寄發日期將延遲至二零二六年三月十三日或之前。 承董事會命 大森控股集團有限公司 孫湧濤 主席 香港， ...

Core Viewpoint - Aidi Te (301580.SZ) is progressing with the construction of its dental industrial park as planned, expected to commence production in the second half of this year, which will significantly enhance the company's overall capacity [1] Group 1 - The construction of the dental industrial park is on schedule and will begin production in the latter half of the year [1] - The company plans to release the new park's capacity in phases, aligning it with market demand and order forecasts to ensure efficient utilization of the new capacity [1] - The strategy aims to match the pace of capacity release with the growth rate of orders, ensuring orderly digestion and effective use of the increased capacity [1]

Core Viewpoint - The company, Aidi Te (301580.SZ), positions itself to serve dental laboratories and oral hospitals/clinics by providing dental materials, equipment, and comprehensive digital solutions, without directly engaging in downstream operations and production [1] Group 1 - The company focuses on technology output and capacity empowerment to deliver full-process digital solutions to downstream partners [1]

Core Viewpoint - The company is making significant progress in its 3D printing business, which is expected to become a new core performance driver with notable advantages [1] Group 1: 3D Printing Business Development - The company's 3D printing business is advancing well and is anticipated to be a new core performance engine [1] - The EZprint-P1 printer offers high-speed printing capabilities, completing a half-arch bridge in just 20 minutes, significantly enhancing industry production efficiency [1] - The printing materials used have a solid content of 53% and have received FDA certification, with domestic and EU certifications expected to be finalized soon [1] Group 2: Market Potential and Applications - The company believes the dental 3D printing market has vast development and growth potential [1] - The maturity of 3D printing products and technologies is continuously improving, with applications expanding into various fields such as implants and orthodontics [1] - Relevant clinical solutions have completed market validation, supporting the company's strategic direction [1] Group 3: Competitive Advantage - The company leverages a full-chain layout advantage in materials, equipment, and solutions to deepen its focus on the 3D printing business [1]

| 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01580 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,500,000,000 | HKD | | 0.02 | HKD | | 30,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 1,500,000,000 | HKD | | 0.02 | HKD | | 30,000,000 | 本月底法定/註冊股本總額： HKD 30,000,000 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 大森控股集團有限公司 呈交日期: 2026 ...

Core Viewpoint - The company, Aidi Te (301580.SZ), is optimistic about its 3D printing business, which is expected to become a new core performance driver with significant advantages [1] Group 1: 3D Printing Business Development - The company's 3D printing business is progressing well and is anticipated to be a new core performance engine [1] - The EZprint-P1 printer has a high-speed printing advantage, capable of completing a half-arch bridge print in 20 minutes, significantly enhancing production efficiency in the industry [1] - The printing materials used have a solid content of 53% and have received FDA certification, with domestic and EU certifications expected to be finalized soon [1] Group 2: Market Potential and Applications - The company believes the dental 3D printing market has vast development and growth potential [1] - The maturity of 3D printing products and technologies is continuously improving, with applications expanding into various fields such as implants and orthodontics [1] - Relevant clinical solutions have completed market validation, supporting the company's strategic direction [1] Group 3: Competitive Advantage - The company leverages its full-chain layout advantages in materials, equipment, and solutions to deepen its focus on the 3D printing business [1]

Core Viewpoint - The company anticipates that its overall revenue growth pace in 2025 will remain consistent with the first three quarters, with profit growth outpacing revenue growth [1] Group 1: Revenue and Profit Growth - The company reported a good growth in profitability, with profit growth rate exceeding that of revenue growth [1] - The company has not triggered any conditions for performance forecast disclosure, and specific operational data for the fourth quarter and the entire year will be provided in the upcoming annual report [1] Group 2: Global Market Expansion - The company is actively advancing its global market layout, with an increase in the proportion of overseas business revenue compared to the previous year, which has become a significant support for revenue growth [1] - The expansion into international markets has further diversified the company's revenue structure and mitigated operational risks [1] Group 3: Product Structure Optimization - The company has made positive progress in optimizing its product structure, leading to a steady improvement in overall operational quality [1]

Core Viewpoint - The company is currently operating at a high overall capacity utilization rate and is enhancing its production capabilities through automation upgrades and optimization of core production processes to meet order demands [1] Group 1: Production Capacity - The company is continuously exploring the potential of existing capacity to achieve endogenous capacity enhancement [1] - The construction of the new park is progressing as planned and is expected to commence production in the second half of the year [1] - The company plans to gradually release and rationally expand the capacity of the new park based on market demand and predictable order situations [1] Group 2: Cost Management - According to the company's rigorous calculations, the new park's asset stabilization will not exert pressure on the overall cost side of the company [1]

香港联交所最新资料显示，1月26日，大森控股(01580)股东将股票由金利丰证券转入高歌证券，转仓市 值4854.16万港元，占比11.08%。 大森控股公布，于2026年1月22日，公司控股股东黄振汉先生出售1.197亿股公司股份，相当于公司于公 告日期已发行股本约10.92%。紧随出售事项完成后，黄振汉先生实益拥有约6.225亿股股份，相当于公 司已发行股本约56.82%，黄振汉先生仍为公司控股股东。 ...

Core Viewpoint - The recent stock transfer and share sale by the major shareholder of Da Sen Holdings indicates significant changes in ownership structure and potential implications for the company's governance and market perception [1] Group 1: Shareholder Activity - On January 26, Da Sen Holdings' shareholder transferred shares worth HKD 48.54 million from Jin Li Fung Securities to Gao Ge Securities, representing 11.08% of the total shares [1] - On January 22, 2026, the controlling shareholder, Mr. Huang Zhenhan, sold 119.7 million shares, equivalent to approximately 10.92% of the company's issued share capital at the time of the announcement [1] - Following the sale, Mr. Huang Zhenhan retains approximately 622.5 million shares, which is about 56.82% of the total issued share capital, maintaining his status as the controlling shareholder of the company [1]